Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $379.51 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $165.64 | 2 | $0 (2017) |
| Amgen Inc. | $142.67 | 2 | $0 (2019) |
| ABBVIE INC. | $71.20 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $32.16 | 2 | ABBVIE INC. ($32.16) |
| 2022 | $27.42 | 2 | ABBVIE INC. ($27.42) |
| 2021 | $11.62 | 1 | AbbVie Inc. ($11.62) |
| 2019 | $40.91 | 1 | Amgen Inc. ($40.91) |
| 2017 | $267.40 | 3 | Novartis Pharmaceuticals Corporation ($165.64) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/02/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/12/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/26/2022 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/09/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/27/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/15/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $40.91 | General |
| Category: Cardiology | ||||||
| 09/13/2017 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $101.76 | General |
| Category: Endocrinology | ||||||
| 04/26/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $88.29 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/24/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $77.35 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 271 | 291 | $93,720 | $29,695 |
| 2022 | 4 | 262 | 285 | $67,101 | $23,112 |
| 2021 | 4 | 312 | 325 | $75,373 | $27,208 |
| 2020 | 4 | 300 | 321 | $64,698 | $22,878 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 90 | 97 | $42,292 | $14,300 | 33.8% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 143 | 155 | $44,795 | $13,563 | 30.3% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 27 | 28 | $5,236 | $1,476 | 28.2% |
| 99282 | Emergency department visit with straightforward medical decision making | Facility | 2023 | 11 | 11 | $1,397 | $356.46 | 25.5% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 117 | 133 | $37,972 | $13,863 | 36.5% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 94 | 101 | $18,770 | $5,664 | 30.2% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 13 | 13 | $5,605 | $2,328 | 41.5% |
| 99282 | Emergency department visit for problem of mild to moderate severity | Facility | 2022 | 38 | 38 | $4,754 | $1,257 | 26.4% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 151 | 163 | $44,156 | $16,469 | 37.3% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 87 | 87 | $15,351 | $4,860 | 31.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 24 | 24 | $9,785 | $4,274 | 43.7% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2021 | 50 | 51 | $6,081 | $1,605 | 26.4% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 122 | 131 | $33,012 | $13,059 | 39.6% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 111 | 121 | $19,723 | $5,730 | 29.1% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 16 | 16 | $6,080 | $2,480 | 40.8% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2020 | 51 | 53 | $5,883 | $1,608 | 27.3% |
About Dr. Valerie Kupferer, D.O
Dr. Valerie Kupferer, D.O is a Emergency Medicine healthcare provider based in Murphysboro, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003869280.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Valerie Kupferer, D.O has received a total of $379.51 in payments from pharmaceutical and medical device companies, with $32.16 received in 2023. These payments were reported across 9 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($379.51).
As a Medicare-enrolled provider, Kupferer has provided services to 1,145 Medicare beneficiaries, totaling 1,222 services with total Medicare billing of $102,893. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Family Medicine
- Location Murphysboro, IL
- Active Since 05/18/2006
- Last Updated 02/08/2021
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1003869280
Products in Payments
- ENTRESTO (Drug) $165.64
- Prolia (Biological) $101.76
- DALVANCE (Drug) $56.89
- Repatha (Biological) $40.91
- AVYCAZ (Drug) $14.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.